These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20058178)

  • 1. Mass spectrometric analysis of body fluids for biomarker discovery.
    Good DM; Coon JJ
    Methods Mol Biol; 2009; 566():277-91. PubMed ID: 20058178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Employment of complementary dissociation techniques for body fluid characterization and biomarker discovery.
    Good DM; Rutishauser D
    Methods Mol Biol; 2013; 1002():223-32. PubMed ID: 23625407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-accuracy proteome maps of human body fluids.
    Schmidt A; Aebersold R
    Genome Biol; 2006; 7(11):242. PubMed ID: 17140426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass Spectrometric Identification of Endogenous Peptides.
    Azkargorta M; Escobes I; Iloro I; Elortza F
    Methods Mol Biol; 2018; 1719():59-70. PubMed ID: 29476504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sample preparation and bioanalysis in mass spectrometry].
    Bourgogne E; Wagner M
    Ann Biol Clin (Paris); 2015; 73(1):11-23. PubMed ID: 25582719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-mass spectrometry: quantification of low-abundance proteins in biological fluids.
    Kulasingam V; Smith CR; Batruch I; Diamandis EP
    Methods Mol Biol; 2011; 728():207-18. PubMed ID: 21468950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sampling and analytical strategies for biomarker discovery using mass spectrometry.
    Conrads TP; Hood BL; Veenstra TD
    Biotechniques; 2006 Jun; 40(6):799-805. PubMed ID: 16774124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved peptide identification for proteomic analysis based on comprehensive characterization of electron transfer dissociation spectra.
    Sun RX; Dong MQ; Song CQ; Chi H; Yang B; Xiu LY; Tao L; Jing ZY; Liu C; Wang LH; Fu Y; He SM
    J Proteome Res; 2010 Dec; 9(12):6354-67. PubMed ID: 20883037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-line LC-MS approach combining collision-induced dissociation (CID), electron-transfer dissociation (ETD), and CID of an isolated charge-reduced species for the trace-level characterization of proteins with post-translational modifications.
    Wu SL; Hühmer AF; Hao Z; Karger BL
    J Proteome Res; 2007 Nov; 6(11):4230-44. PubMed ID: 17900180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.
    Magni F; Van Der Burgt YE; Chinello C; Mainini V; Gianazza E; Squeo V; Deelder AM; Kienle MG
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s92-7. PubMed ID: 20606758
    [No Abstract]   [Full Text] [Related]  

  • 11. Mass spectrometry based proteomics in urine biomarker discovery.
    Theodorescu D; Mischak H
    World J Urol; 2007 Oct; 25(5):435-43. PubMed ID: 17703310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.
    Kolch W; Neusüss C; Pelzing M; Mischak H
    Mass Spectrom Rev; 2005; 24(6):959-77. PubMed ID: 15747373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens.
    Reuschel SA; Eades D; Foltz RL
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):145-59. PubMed ID: 10572980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids.
    Nelson CC; Foltz RL
    J Chromatogr; 1992 Sep; 580(1-2):97-109. PubMed ID: 1400834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of ETD mass spectrometry in proteomic analysis.
    Mikesh LM; Ueberheide B; Chi A; Coon JJ; Syka JE; Shabanowitz J; Hunt DF
    Biochim Biophys Acta; 2006 Dec; 1764(12):1811-22. PubMed ID: 17118725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.
    De Bock M; de Seny D; Meuwis MA; Chapelle JP; Louis E; Malaise M; Merville MP; Fillet M
    J Biomed Biotechnol; 2010; 2010():906082. PubMed ID: 20029632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of electron transfer dissociation mass spectrometry.
    Good DM; Wirtala M; McAlister GC; Coon JJ
    Mol Cell Proteomics; 2007 Nov; 6(11):1942-51. PubMed ID: 17673454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in protein profiling of tissues and tissue fluids.
    Yang S; Huang CM
    Expert Rev Proteomics; 2007 Aug; 4(4):515-29. PubMed ID: 17705709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive comparison of collision induced dissociation and electron transfer dissociation.
    Molina H; Matthiesen R; Kandasamy K; Pandey A
    Anal Chem; 2008 Jul; 80(13):4825-35. PubMed ID: 18540640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric de novo sequencing of natural non-tryptic peptides: comparing peculiarities of collision-induced dissociation (CID) and high energy collision dissociation (HCD).
    Samgina TY; Vorontsov EA; Gorshkov VA; Artemenko KA; Zubarev RA; Lebedev AT
    Rapid Commun Mass Spectrom; 2014 Dec; 28(23):2595-604. PubMed ID: 25366406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.